Latest Management of cancer Stories

2014-05-06 16:33:11

Hope Summit and New Scientific Grant Applications Kick Off Lung Cancer Hope Month WASHINGTON, May 6, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer nonprofit, commemorates May, Lung Cancer Hope Month, as a time to celebrate the hope and promise of science in the ongoing quest for a world where no one dies from lung cancer. LUNGevity Foundation President and CEO Andrea Stern Ferris noted the remarkable progress in lung cancer treatments, growth of lung...

2014-05-05 08:28:31

New Data Include Results on Oncotype DX's Prognosis of Late Recurrence in Invasive Breast Cancer and Clinical Utility in Ductal Carcinoma In Situ (DCIS) REDWOOD CITY, Calif., May 5, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from nine studies of Oncotype DX(®) in breast, colon, prostate and renal cancer will be presented at the American Society of Clinical Oncology(®) (ASCO(®)) Annual Meeting, taking place May 30 - June 3, 2014 at McCormick Place...

2014-05-02 08:25:16

Large Study Published in The Oncologist Underscores Test's Value in Guiding Treatment Decisions REDWOOD CITY, Calif., May 2, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that The Oncologist published positive results from an Oncotype DX(®) colon cancer decision impact study, demonstrating that Recurrence Score(®) results changed treatment recommendations in 45 percent of stage II colon cancer patients. The study was conducted in collaboration with the...

2014-05-01 23:07:27

Cianna Medical: Early-stage breast cancer treatment enables more women to opt for partial breast radiation. Aliso Viejo, CA (PRWEB) May 01, 2014 Cianna Medical, Inc., a women’s health company, today announced the results of a trial examining the long-term side effects of strut-based brachytherapy for early-stage breast cancer. According to researchers, treatment with SAVI® breast brachytherapy resulted in very low rates of late toxicities, even in patients with minimal space...

Protein Discovery Could Boost Efficacy Of Bone Marrow Replacement Treatments
2014-05-01 03:38:51

University of California - San Diego Researchers at the University of California, San Diego School of Medicine report that a protein called beta-catenin plays a critical, and previously unappreciated, role in promoting recovery of stricken hematopoietic stem cells after radiation exposure. The findings, published in the May 1 issue of Genes and Development, provide a new understanding of how radiation impacts cellular and molecular processes, but perhaps more importantly, they suggest...

2014-05-01 08:36:08

CAMBRIDGE, Mass., May 1, 2014 /PRNewswire-USNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in the following conferences in May: -- Cancer Advance NY at Apella Event Space in New York on Wednesday, May 14 at 1:00 p.m. ET, discussing protein methyltransferase inhibitors as cancer therapeutics. -- UBS...

2014-04-30 08:31:39

DUBLIN, Apr. 30, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/wzl2nj/tissue) has announced the addition of the "Tissue Diagnostics Market by Technology, Disease, Product, End-Users & Region - Trends & Forecast to 2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Tissue diagnostics is used to determine the stage, prognosis, and treatment course of cancer. According to estimates by the International Agency for...

2014-04-28 23:09:34

Austin-based tech company, Photetica, is now in the clinical trial phase with its newest medical device, Lazarus, and has launched a crowdfunding campaign through Indiegogo to support clinical studies. Austin, TX (PRWEB) April 28, 2014 Lazarus, the patented medical technology designed to prevent and reverse chemotherapy side effects during breast cancer treatment, today announced their global launch to secure funds for clinical trials through Indiegogo. Photetica has been working on...

2014-04-28 08:31:47

HACKENSACK, N.J., April 28, 2014 /PRNewswire/ -- Results from a study published in Clinical Cancer Research demonstrate that oncologists were able to accurately predict which therapies patients would respond to by using a combination of next-generation sequencing and drug sensitivity testing in mouse avatars (Champions TumorGrafts®) developed by Champions Oncology (OTC: CSBR). The paper, titled "Integrated Next Generation Sequencing and Avatar Mouse Models for Personalized Cancer...

2014-04-25 12:26:33

DUBLIN, Apr. 25, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/dj4r99/global_testicular) has announced the addition of the "Global Testicular Cancer Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The current trend witnessed by the Global Testicular Cancer Drugs market is combination therapy being used for treating testicular cancer. Several oncologists believe that chemotherapy drugs are most...

Word of the Day
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'